Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1996 Mar;55(3):202–204. doi: 10.1136/ard.55.3.202

Salivary eicosanoid concentration in patients with Sjögren's syndrome.

M Tishler 1, I Yaron 1, A Raz 1, F A Meyer 1, M Yaron 1
PMCID: PMC1010131  PMID: 8712887

Abstract

OBJECTIVE: To investigate eicosanoid concentrations in the saliva of patients with primary Sjögren's syndrome (SS). METHODS: Whole mixed saliva of 36 subjects was assayed for eicosanoid concentrations using a radioimmunoassay. Patients with primary SS having positive lip biopsy served as the study group; their results were compared with data from patients with dry mouth and negative lip biopsy (dry mouth group), and with a group of normal healthy controls. RESULTS: Concentrations of thromboxane B2 were significantly (p < 0.01) increased in 18 patients with primary SS compared with 10 patients with dry mouth and eight healthy normal controls (1.95 (SD 0.51) ng/ml saliva compared with 0.52 (0.1) ng/ml and 0.3 (0.1) ng/ml, respectively). Similarly, prostaglandin E2 concentrations were also significantly increased (p < 0.01) in 11 patients with primary SS compared with five patients with dry mouth and eight normal controls (3.75 (0.82) ng/ml saliva compared with 0.32 (0.1) ng/ml and 0.41 (0.1) ng/ml, respectively). CONCLUSION: Salivary concentrations of eicosanoids are significantly increased in patients with primary SS, and this may prove helpful in the diagnosis of this disease.

Full text

PDF
202

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ben-Aryeh H., Spielman A., Szargel R., Gutman D., Scharf J., Nahir M., Scharf Y. Sialochemistry for diagnosis of Sjögren's syndrome in xerostomic patients. Oral Surg Oral Med Oral Pathol. 1981 Nov;52(5):487–490. doi: 10.1016/0030-4220(81)90359-5. [DOI] [PubMed] [Google Scholar]
  2. Daniels T. E. Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum. 1984 Feb;27(2):147–156. doi: 10.1002/art.1780270205. [DOI] [PubMed] [Google Scholar]
  3. Lefkowith J. B., Flippo V., Sprecher H., Needleman P. Paradoxical conservation of cardiac and renal arachidonate content in essential fatty acid deficiency. J Biol Chem. 1985 Dec 15;260(29):15736–15744. [PubMed] [Google Scholar]
  4. Nishino S., Ueno R., Ohishi K., Sakai T., Hayaishi O. Salivary prostaglandin concentrations: possible state indicators for major depression. Am J Psychiatry. 1989 Mar;146(3):365–368. doi: 10.1176/ajp.146.3.365. [DOI] [PubMed] [Google Scholar]
  5. Rigas B., Korenberg J. R., Merrill W. W., Levine L. Prostaglandins E2 and E2 alpha are elevated in saliva of cystic fibrosis patients. Am J Gastroenterol. 1989 Nov;84(11):1408–1412. [PubMed] [Google Scholar]
  6. Rigas B., Levine L. Concentrations of arachidonic-acid metabolites in human mixed saliva are independent of flow rate. Arch Oral Biol. 1983;28(12):1135–1137. doi: 10.1016/0003-9969(83)90171-1. [DOI] [PubMed] [Google Scholar]
  7. Rigas B., Levine L. Human salivary eicosanoids: circadian variation. Biochem Biophys Res Commun. 1983 Aug 30;115(1):201–205. doi: 10.1016/0006-291x(83)90989-0. [DOI] [PubMed] [Google Scholar]
  8. Rigas B., Lewis R. A., Austen K. F., Corey E. J., Levine L. Identification and quantitation of arachidonic-acid metabolic products in rabbit, rat and human saliva. Arch Oral Biol. 1983;28(11):1031–1035. doi: 10.1016/0003-9969(83)90058-4. [DOI] [PubMed] [Google Scholar]
  9. Schiødt M., Thorn J. Criteria for the salivary component of Sjögren's syndrome. A review. Clin Exp Rheumatol. 1989 Mar-Apr;7(2):119–122. [PubMed] [Google Scholar]
  10. Skopouli F. N., Fox P. C., Galanopoulou V., Atkinson J. C., Jaffe E. S., Moutsopoulos H. M. T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome. J Rheumatol. 1991 Feb;18(2):210–214. [PubMed] [Google Scholar]
  11. Speight P. M., Kaul A., Melsom R. D. Measurement of whole unstimulated salivary flow in the diagnosis of Sjögren's syndrome. Ann Rheum Dis. 1992 Apr;51(4):499–502. doi: 10.1136/ard.51.4.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Vitali C., Bombardieri S., Moutsopoulos H. M., Balestrieri G., Bencivelli W., Bernstein R. M., Bjerrum K. B., Braga S., Coll J., de Vita S. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993 Mar;36(3):340–347. doi: 10.1002/art.1780360309. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES